KEMIRIX v1.0 · Target Release: February 5th 2027 · Africa First. World Next. · 30 Critical Healthcare Problems. One Platform. · Clinical AI for 1.4 Billion Africans · KEMIRIX v1.0 · Target Release: February 5th 2027 · Africa First. World Next. · 30 Critical Healthcare Problems. One Platform. · Clinical AI for 1.4 Billion Africans ·
KEMIRIX

Partner With Us

Build the Future ofGlobal Healthcare AI

We are actively seeking hospitals, research institutions, distribution partners, and strategic investors to build the clinical AI infrastructure Africa needs.

🏥

Track 1

Hospital Partner Program

Deploy KEMIRIX at your facility as a founding pilot institution. Shape the product that will define clinical AI in Africa. We are onboarding a limited number of founding hospitals in 2026 — facilities that will become the first to pilot Africa’s most advanced clinical decision support platform.

  • Early access to KEMIRIX v1.0 before public launch
  • Dedicated implementation and integration support
  • Co-authorship of clinical validation research
  • Preferential pricing as a founding pilot partner
  • Direct input into product roadmap and feature prioritisation
  • Joint press release and case study publication
Apply as Hospital Partner →

What to Expect

01
Initial consultation call (30 min)
We understand your clinical environment and EHR infrastructure.
02
Pilot scoping
We design a deployment plan tailored to your facility's needs and workflows.
03
KEMIRIX deployment
Integration with your systems, staff training, and go-live support.
04
Clinical validation
Joint data collection and co-authorship on outcomes research.
🔬

Track 2

Research Partnership

Partner with KEMIRIX to co-develop peer-reviewed studies on AI-assisted clinical outcomes in African populations. We are actively seeking academic medical centres, schools of public health, and pharmacogenomics research groups.

  • Access to de-identified clinical data (future, with ethics approval)
  • Joint grant application support across WHO, NIH, and Wellcome Trust
  • Co-authorship on peer-reviewed publications
  • KEMIRIX academic research license
  • Access to KEMIRIX clinical validation dataset
  • Dedicated research engineering support
Apply for Research Partnership →

Research Areas of Interest

Clinical outcomes of AI-assisted prescribing in low-resource settings

Pharmacogenomics prevalence and clinical relevance in African populations

Drug-traditional medicine interactions: African TM knowledge mapping

Offline AI inference accuracy in rural clinical environments

Health equity impact of CDS deployment across income-disparate facilities

Antimicrobial resistance guidance and stewardship in sub-Saharan Africa

🌐

Track 3

Distribution Partnership

Bring KEMIRIX to health systems, governments, and clinic networks across your region. We are looking for distribution partners who have established relationships with healthcare institutions in their target markets and the operational capacity to support clinical software deployments.

  • Competitive revenue share model
  • Full technical and clinical training programme
  • Marketing co-investment for your region
  • Regional exclusivity options available
  • Dedicated partner success manager
  • Priority support SLA
Inquire About Distribution →

Ideal Distribution Partner

We are looking for partners who:

  • Have established relationships with hospital systems or government health ministries
  • Operate in one or more African or emerging market countries
  • Have a team capable of supporting SaaS clinical software implementation
  • Understand the regulatory landscape for SaMD in their target market
  • Are committed to improving clinical outcomes — not just closing deals
💼

Track 4

Strategic Investment

Join us at the ground floor of Africa’s clinical AI revolution. KEMIRIX is a first-mover in a category that does not yet exist at scale — and is building the infrastructure that will define healthcare in the world’s fastest-growing region.

We are pursuing seed investment to accelerate our hospital pilot programme, strengthen our regulatory pathway, and expand our clinical knowledge base. We welcome conversations with healthcare-focused VCs, impact investors, and strategic corporate investors.

Investor Inquiry →
$45B
Global CDS Market
Total addressable market
$2.1B
Sub-Saharan Africa Healthcare AI
Projected by 2030 (Deloitte)
First-mover
KEMIRIX Position
Africa-native CDS platform
January 2026
Founded
Kenya · India
For detailed financials, market sizing data, and pitch deck, please submit an investor inquiry and we will respond within 48 hours with our investor package.

Get In Touch

Submit a Partnership Inquiry

Select your partnership type above and submit an inquiry. We respond to all partnership enquiries within 48 hours. Alternatively, email us directly at admin@kemirix.com

Loading form...